1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Europe Therapeutic Vaccines Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Chronic Conditions

4.1.2 Increasing Investments and Funding for Vaccine Development

4.2 Market Restraints

4.2.1 Regulatory Challenges

4.3 Market Opportunities

4.3.1 Extending Product Pipeline

4.4 Future Trends

4.4.1 Advancements in Vaccine Technology

4.5 Impact of Drivers and Restraints:

5. Therapeutic Vaccines Market - Europe Market Analysis

5.1 Europe Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

5.2 Europe Therapeutic Vaccines Market Forecast Analysis

6. Europe Therapeutic Vaccines Market Analysis - by Product

6.1 Cancer Vaccine

6.1.1 Overview

6.1.2 Cancer Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.2 infectious Disease Vaccine

6.2.1 Overview

6.2.2 infectious Disease Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.3 Others

6.3.1 Overview

6.3.2 Others: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7. Europe Therapeutic Vaccines Market Analysis - by Technology

7.1 Allogenic Vaccine

7.1.1 Overview

7.1.2 Allogenic Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7.2 Autologous Vaccine

7.2.1 Overview

7.2.2 Autologous Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Europe Therapeutic Vaccines Market Analysis - by End User

8.1 Hospitals

8.1.1 Overview

8.1.2 Hospitals: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.2 Clinics

8.2.1 Overview

8.2.2 Clinics: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.3 Others

8.3.1 Overview

8.3.2 Others: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Europe Therapeutic Vaccines Market - Country Analysis

9.1 Europe

9.1.1 Europe Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.1 Europe Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.2 Germany: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.2.1 Germany: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.2.2 Germany: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.2.3 Germany: Europe Therapeutic Vaccines Market Share - by End User

9.1.1.3 United Kingdom: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.3.1 United Kingdom: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.3.2 United Kingdom: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.3.3 United Kingdom: Europe Therapeutic Vaccines Market Share - by End User

9.1.1.4 France: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.4.1 France: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.4.2 France: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.4.3 France: Europe Therapeutic Vaccines Market Share - by End User

9.1.1.5 Italy: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.5.1 Italy: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.5.2 Italy: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.5.3 Italy: Europe Therapeutic Vaccines Market Share - by End User

9.1.1.6 Spain: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.6.1 Spain: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.6.2 Spain: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.6.3 Spain: Europe Therapeutic Vaccines Market Share - by End User

9.1.1.7 Rest of Europe: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.7.1 Rest of Europe: Europe Therapeutic Vaccines Market Share - by Product

9.1.1.7.2 Rest of Europe: Europe Therapeutic Vaccines Market Share - by Technology

9.1.1.7.3 Rest of Europe: Europe Therapeutic Vaccines Market Share - by End User

10. Therapeutic Vaccines Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Therapeutic Vaccines Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Dendreon

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 BioNTech SE

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Serum Institute of India Pvt. Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck & Co Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Amgen Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 ISA Pharmaceuticals BV

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 INOVIO Pharmaceuticals Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Transgene SA

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 THERAVECTYS SA

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 CureVac SE

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. Europe Therapeutic Vaccines Market Segmentation

Table 2. Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Table 3. Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Product

Table 4. Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Technology

Table 5. Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User

Table 6. Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country

Table 7. Germany: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 8. Germany: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 9. Germany: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 10. United Kingdom: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 11. United Kingdom: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 12. United Kingdom: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 13. France: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 14. France: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 15. France: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 16. Italy: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 17. Italy: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 18. Italy: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 19. Spain: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 20. Spain: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 21. Spain: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 22. Rest of Europe: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 23. Rest of Europe: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 24. Rest of Europe: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 25. Recent Organic Growth Strategies in the Therapeutic Vaccines Market

Table 26. Recent Inorganic Growth Strategies in the Therapeutic Vaccines Market

Table 27. Glossary of Terms, Therapeutic Vaccines Market

List of Figures

Figure 1. Europe Therapeutic Vaccines Market Segmentation - Country

Figure 2. Europe Therapeutic Vaccines Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

Figure 5. Europe Therapeutic Vaccines Market Share (%) - by Product (2024 and 2031)

Figure 6. Cancer Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 7. infectious Disease Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 8. Others: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 9. Europe Therapeutic Vaccines Market Share (%) - by Technology (2024 and 2031)

Figure 10. Allogenic Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 11. Autologous Vaccine: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 12. Europe Therapeutic Vaccines Market Share (%) - by End User (2024 and 2031)

Figure 13. Hospitals: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 14. Clinics: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 15. Others: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 16. Europe Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 17. Germany: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 18. United Kingdom: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 19. France: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 20. Italy: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 21. Spain: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 22. Rest of Europe: Europe Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 23. Growth Strategies in the Therapeutic Vaccines Market